Immunopeptidomics-guided cancer vaccine design: Advances, challenges, and emerging opportunities.

Behzadifar MM, Shadkam M, Kazemi S, Mirsamiei E, Hoseinzadeh A, Nickho H, Baharlou R

Open source

DOI
10.1016/j.biopha.2026.119926
Published
2026 Sep 15
Container
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.biopha.2026.119926,
  title = {Immunopeptidomics-guided cancer vaccine design: Advances, challenges, and emerging opportunities.},
  author = {Behzadifar MM and Shadkam M and Kazemi S and Mirsamiei E and Hoseinzadeh A and Nickho H and Baharlou R},
  year = {2026},
  journal = {Biomedicine \& pharmacotherapy = Biomedecine \& pharmacotherapie},
  doi = {10.1016/j.biopha.2026.119926},
  url = {https://doi.org/10.1016/j.biopha.2026.119926}
}

RIS

TY  - JOUR
TI  - Immunopeptidomics-guided cancer vaccine design: Advances, challenges, and emerging opportunities.
AU  - Behzadifar MM
AU  - Shadkam M
AU  - Kazemi S
AU  - Mirsamiei E
AU  - Hoseinzadeh A
AU  - Nickho H
AU  - Baharlou R
PY  - 2026
JO  - Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
DO  - 10.1016/j.biopha.2026.119926
UR  - https://doi.org/10.1016/j.biopha.2026.119926
ER  - 

APA

MM, B., M, S., S, K., E, M., A, H., H, N., & R, B. (2026). Immunopeptidomics-guided cancer vaccine design: Advances, challenges, and emerging opportunities.. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. https://doi.org/10.1016/j.biopha.2026.119926

Source records